Hilltop National Bank’s Novavax NVAX Stock Holding History

Hilltop National Bank’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.25K	Hold	208	–	–	﹤0.01%	744
2026 Q2	$1.96K	Hold	208	–	–	﹤0.01%	769
2026 Q1	$1.69K	Hold	208	–	–	﹤0.01%	760
2025 Q4	$1.4K	Hold	208	–	–	﹤0.01%	755
2025 Q3	$1.8K	Hold	208	–	–	﹤0.01%	756
2025 Q2	$1.31K	Buy	+208	New	+$1.38K	﹤0.01%	763
2024 Q4	$281	Hold	35	–	–	﹤0.01%	769
2024 Q3	$442	Hold	35	–	–	﹤0.01%	801
2024 Q2	$443	Hold	35	–	–	﹤0.01%	808
2024 Q1	$167	Buy	+35	New	+$162	﹤0.01%	795

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $397M AUM 31.23% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

Hilltop National Bank's NVAX Position: Q3 2026 in Review

Hilltop National Bank held its Novavax (NVAX) position steady in Q3 2026 at 208 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Hilltop National Bank first reported a position in NVAX in Q1 2024 and has held it in 10 quarters since. 19 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

Hilltop National Bank held 208 shares of Novavax worth $2.25K as of Q3 2026.
Hilltop National Bank left its Novavax share count unchanged in Q3 2026.
Novavax made up ﹤0.01% of Hilltop National Bank's portfolio in Q3 2026, its #744 holding.
Hilltop National Bank first reported a position in Novavax in Q1 2024 and has held it in 10 quarters since.
19 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Hilltop National Bank's 13F filing for Q3 2026, filed 14 Oct 2026.